1-92246626-GAA-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_053274.3(GLMN):c.1687_1688delTT(p.Phe563HisfsTer3) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_053274.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLMN | ENST00000370360.8 | c.1687_1688delTT | p.Phe563HisfsTer3 | frameshift_variant | Exon 19 of 19 | 1 | NM_053274.3 | ENSP00000359385.3 | ||
GLMN | ENST00000495106.5 | n.*348_*349delTT | non_coding_transcript_exon_variant | Exon 18 of 18 | 1 | ENSP00000436829.1 | ||||
GLMN | ENST00000495106.5 | n.*348_*349delTT | 3_prime_UTR_variant | Exon 18 of 18 | 1 | ENSP00000436829.1 | ||||
GLMN | ENST00000471465.1 | n.633_634delTT | non_coding_transcript_exon_variant | Exon 3 of 3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Glomuvenous malformation Uncertain:1
The GLMN c.1687_1688del (p.Phe563HisfsTer3) variant was identified at an allelic fraction consistent with somatic origin. This variant, to our knowledge, has not been reported in the medical literature. This variant is absent from the general population (gnomAD v.3.1.2), indicating it is not a common variant. This variant causes a frameshift by deleting two nucleotides, leading to a premature termination codon; however, because this occurs in the last exon, this is not predicted to lead to nonsense-mediated decay. Loss-of-function variants have been reported in glomuvenous malformation and Blue rubber bleb nevus syndrome (Brouillard P et al., PMID: 15689436, Borroni RG et al., PMID: 24961656; Borroni RG et al., PMID: 24345188; Brouillard P et al., PMID: 23801931; Amyere M et al., PMID: 23375657; Brouillard P et al., PMID: 11845407; Yin J et al., PMID: 31793416). A concurrent variant at a heterozygous allelic fraction, GLMN c.395-1G>C, is identified; however, whether these variants are in cis or trans, can not be determined by this assay. The GLMN c.1687_1688del (p.Phe563HisfsTer3) variant is predicted to result in a loss of function allele. The two-hit model for glomuvenous malformations involving the GLMN gene has been reported in the literature (Brouillard P et al., PMID: 23801931; Brouillard P et al., PMID: 15689436; Amyere M et al., PMID: 23375657; Amyere M et al., PMID: 23375657; Borroni RG et al., PMID: 24961656; Brouillard et al., PMID: 11845407). Due to limited information and based on an internally-developed protocol informed by the ACMG/AMP guidelines (Richards S et al., PMID: 25741868) and gene-specific practices from the ClinGen Criteria Specification Registry, the clinical significance of this variant is uncertain at this time. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.